Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Pacific Biosciences of California, Inc. (PACB) Q4 2023 Earnings Call Transcript
06:39pm, Thursday, 15'th Feb 2024
Pacific Biosciences of California, Inc. (PACB) Q4 2023 Earnings Call Transcript
Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates
06:31pm, Thursday, 15'th Feb 2024
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.35 per share a year ago.
7 Stocks Cathie Wood Is Still Loading Up On in Q1
01:59pm, Tuesday, 13'th Feb 2024
You can't say Cathie Wood is afraid to make big bets. The investing guru is more than willing to lay it all on the line for stocks she believes in.
PacBio's (PACB) New Kits to Boost Its Revio Sequencing System
10:47am, Tuesday, 06'th Feb 2024
PacBio's (PACB) new library preparation kits are likely to boost Revio's long-read sequencing systems by reducing cost and workflow time.
PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction
01:32pm, Tuesday, 16'th Jan 2024
PacBio's (PACB) new offering, PanDNA kit, is likely to help researchers effectively extract DNA optimized for HiFi sequencing. This versatile Nanobind kit is expected to be available in February 2024.
PacBio (PACB) Preliminary Q4 Revenues Boosted by Revio Sales
12:02pm, Tuesday, 09'th Jan 2024
PacBio's (PACB) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its sequencing systems.
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 27'th Dec 2023
MENLO PARK, Calif. , Dec. 27, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
09:46am, Tuesday, 26'th Dec 2023
PacBio's (PACB) product development activities raise optimism about the stock.
The 3 Best Cathie Wood Stocks to Buy in December
04:00pm, Sunday, 10'th Dec 2023
Cathie Wood stocks have been on a big roll lately, as Ark Innovation ETF (NYSEARCA: ARKK ) soared 31% in November, with Coinbase (NASDAQ: COIN ), Roku (NASDAQ: ROKU ), Shopify (NYSE: SHOP ) and CRISPR
Reassessing Pacific Biosciences: Deep Dive Into Q3 2023 Revenue Surge And Market Dynamics
10:03pm, Monday, 20'th Nov 2023
Pacific Biosciences reported a 72% YoY revenue growth in Q3 2023, driven by the successful launch of their Revio platform. The adoption of Revio by new customers and the potential to convert existing
PacBio (PACB) Tops on Q3 Earnings, Raises FY23 Revenue View
12:46pm, Tuesday, 31'st Oct 2023
PacBio (PACB) witnesses strong revenue growth in the third quarter, partly aided by customers' continued product transition to the Revio system.
Pacific Biosciences of California, Inc. (PACB) Q3 2023 Earnings Call Transcript
10:22pm, Monday, 30'th Oct 2023
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q3 2023 Earnings Conference Call October 30, 2023 4:30 PM ET Company Participants Todd Friedman - Senior Director, Investor Relations Christian H
Three Reasons to Add PacBio (PACB) Stock to Your Portfolio
01:32pm, Friday, 06'th Oct 2023
PacBio's (PACB) product development activities raise optimism about the stock.
Strength Seen in Pacific Biosciences (PACB): Can Its 8.9% Jump Turn into More Strength?
09:01am, Thursday, 14'th Sep 2023
Pacific Biosciences (PACB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price in
Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Market
03:52am, Sunday, 10'th Sep 2023
Pacific Biosciences has a leading position within the fast-growing long-read DNA sequencer market. Moreover, it is expanding its high-accuracy long-read portfolio to grab more market share from Illumi
